{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T03:49:05Z","timestamp":1782186545220,"version":"3.54.5"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BCTT"],"DOI":"10.2147\/bctt.s574628","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T03:10:15Z","timestamp":1782184215000},"page":"1-11","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of CDK4\/6 Inhibitor Plus Aromatase Inhibitor versus Fulvestrant in Chinese Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative (HR+\/HER2-) Advanced Breast Cancer"],"prefix":"10.2147","volume":"Volume 18","author":[{"given":"Yujing","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9392-8259","authenticated-orcid":true,"given":"Cheng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiuda","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanfang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiani","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,6]]},"container-title":["Breast Cancer: Targets and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/116651","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/116651","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T03:10:18Z","timestamp":1782184218000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/efficacy-of-cdk46-inhibitor-plus-aromatase-inhibitor-versus-fulvestran-peer-reviewed-fulltext-article-BCTT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/bctt.s574628","relation":{},"ISSN":["1179-1314"],"issn-type":[{"value":"1179-1314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]}}}